ClinOne Names Clinical Research Technology Leader Andrea Valente Chief Executive Officer
Retrieved on:
Tuesday, March 1, 2022
People, Risk, Genstar Capital, Development, Executive, Partnership, ERT, Growth, Nordic Capital, Medicine, Old age, Awareness, Uncertainty, Pediatrics, Research, OHMS, Industry, Clinical trial, Research and development, Sale, Tony Blair Institute for Global Change, Oracle, API, LinkedIn, News, Caregiver, TransPerfect, Information technology, DCT, Patient, Technology, Humble Bundle, CRO, Solution, CEO, CNS, Harvard Innovation Labs, Cros, Fine chemical, Management, Pharmaceutical industry
01, 2022 /PRNewswire-PRWeb/ -- ClinOne , the true single technology platform to connect, inform, and empower clinical trial patients and sites, has achieved yet another milestone in its evolution by naming venerated industry leader Andrea Valente ( LinkedIn ) as Chief Executive Officer.
Key Points:
- 01, 2022 /PRNewswire-PRWeb/ -- ClinOne , the true single technology platform to connect, inform, and empower clinical trial patients and sites, has achieved yet another milestone in its evolution by naming venerated industry leader Andrea Valente ( LinkedIn ) as Chief Executive Officer.
- Valente joins ClinOne from Medable where she served as Chief Operating Officer.
- At ERT, Valente was the Executive Vice President, Chief Development Officer, and member of the Senior Leadership Team.
- "I'm so excited to join the ClinOne team at this pivotal time in the company's accelerating growth and the industry's overall technology evolution," Valente said.